- Report
- July 2024
- 150 Pages
Global
From €3490EUR$3,750USD£2,919GBP
- Report
- July 2024
- 100 Pages
Global
From €3490EUR$3,750USD£2,919GBP
- Report
- February 2024
- 110 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- July 2025
- 350 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- June 2025
- 400 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- June 2025
- 400 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- May 2023
- 140 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- January 2024
- 110 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- April 2025
- 203 Pages
Global
From €2327EUR$2,500USD£1,946GBP
- Report
- May 2024
- 191 Pages
Global
From €2327EUR$2,500USD£1,946GBP
- Report
- June 2026
- 115 Pages
Mexico
From €2791EUR$2,999USD£2,334GBP
- Report
- May 2025
- 110 Pages
Global
From €4421EUR$4,750USD£3,697GBP
- Report
- July 2024
- 208 Pages
Global
From €5584EUR$6,000USD£4,670GBP
- Report
- July 2025
- 350 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3601EUR$3,869USD£3,011GBP
- Report
- May 2023
- 147 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- June 2025
- 207 Pages
Global
From €4649EUR$4,995USD£3,888GBP
- Report
- June 2024
- 250 Pages
Global
From €4649EUR$4,995USD£3,888GBP
- Report
- June 2024
- 152 Pages
Global
From €4649EUR$4,995USD£3,888GBP
- Report
- March 2024
- 197 Pages
Global
€4649EUR$4,995USD£3,888GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more